07.02.2022 - Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced several executive leadership changes to . Seite 1
SAN CLEMENTE, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced several executive leadership changes to support the company’s future g.
Part of the Wall Street Rebel site. Dedicated to delivering institutional quality market analysis, investor education courses, news, and winning buy/sell recommendations - 100% FREE!
Two Clarksville men who forged a special friendship more than a dozen years ago were reunited recently with the help of the Big Brothers Big Sisters organization.